Canadian Addiction Treatment Centres

What Canadian Addiction Treatment Centres does

Canadian Addiction Treatment Centres (CATC), founded in 1995 and headquartered in Markham, Ontario, is Canada's largest provider of addiction care, operating 75+ rapid-access outpatient clinics, 4 CARF-accredited inpatient residential centres (Trafalgar, GreeneStone, 1000 Islands), 26 integrated specialty pharmacies, and a national virtual intensive outpatient program (VIOP). The organization delivers evidence-based medication-assisted treatment for opioid use disorder — primarily methadone and buprenorphine/naloxone (Suboxone), with Sublocade available at select sites — alongside medically supervised detox, individual/group therapy, psychiatric support, harm reduction services (needle exchange, naloxone kits), and Hepatitis C screening/treatment. Its care model spans three modalities: outpatient clinics with same-day walk-in intake, immersive 30–90 day residential programs, and a PHIPA/PIPEDA-compliant encrypted telehealth platform with ~2,500 graduates to date.

CATC serves individual patients struggling with opioid and substance use disorders across Ontario, New Brunswick, and British Columbia, with 16,000+ patients treated monthly. Outpatient clinic visits and physician services are billed to provincial health plans (OHIP in Ontario, MSP in British Columbia) at no out-of-pocket cost to patients, while inpatient residential programs are typically reimbursed through private insurance with varying coverage levels. Ancillary revenue flows through co-located pharmacy dispensing and grant-funded medication assistance programs. The company also operates under legacy DBA brands including OATC and Towards Recovery (TRC), reflecting acquired outpatient networks. A Physician Advisory Group of seven physicians plus dedicated medical leads at each inpatient site provide clinical governance.

The business is fundamentally a healthcare services operator — its technology layer is functional rather than differentiated, with the VIOP telehealth platform being the most notable proprietary asset. Growth has been driven by provincial geographic expansion (most recently into British Columbia with 6 clinics supporting 1,600+ patients in 2023), acquisition and integration of inpatient facilities, and the buildout of integrated pharmacy dispensing.

Name

Canadian Addiction Treatment Centres

Legal name

Canadian Addiction Treatment Centres

Website

https://canatc.ca

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

251–500 employees

Short description

Canadian Addiction Treatment Centres (CATC) is Canada's largest addiction care provider, operating 75+ outpatient clinics, 4 inpatient centres, 26 integrated pharmacies, and a national virtual program serving 16,000+ patients monthly across Ontario, New Brunswick, and British Columbia with medication-assisted treatment and residential recovery services.

Ownership category

akta.pro rank

Product category

Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (62142), Residential Mental Health and Substance Abuse Facilities (623220), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

akta.pro secondary industry

Residential Substance Use Rehabilitation (Inpatient Rehab) (HLAFACAE)

Keywords

• Outpatient addiction treatment
• Opioid agonist therapy
• Inpatient residential recovery
• Virtual intensive outpatient
• Harm reduction services

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Government-Funded Healthcare Services: Medical services within opioid use disorder treatment programs are covered by provincial health plans including OHIP (Ontario) and MSP (British Columbia). Treatment medication costs may be covered by provincial drug benefit programs, private insurance, or grant programs in Ontario. In BC, OUD treatment medication is covered by MSP with possible additional associated costs.
2. Inpatient Treatment Services: Residential addiction treatment programs offered at three CARF-accredited inpatient centres. Covered by many private insurance plans with varying coverage levels. Programs include medically supervised detox, individual and group therapy, psychiatric support, and aftercare.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Canadian Addiction Treatment Centres (CATC) operates Canada's largest network of addiction treatment services, providing outpatient opioid agonist therapy (methadone, buprenorphine/naloxone/Suboxone, Sublocade), CARF-accredited inpatient residential treatment at three Ontario facilities (Trafalgar, GreeneStone, 1000 Islands), and a Virtual Intensive Outpatient Program delivered via encrypted telehealth. Integrated medical, pharmacy, counselling, harm reduction, and Hepatitis C screening/treatment services are delivered across 75+ outpatient clinics, 4 inpatient centres, and 26 in-clinic pharmacies in Ontario, New Brunswick, and British Columbia.

Product overview

Canadian Addiction Treatment Centres (CATC) operates Canada's largest network of addiction treatment services, consisting of three interconnected care pathways: (1) Outpatient Opioid Treatment via 75+ rapid-access clinics offering medication-assisted therapy with Methadone, Suboxone, and Sublocade; (2) CARF-accredited Inpatient Residential Treatment at three Ontario facilities (Trafalgar, GreeneStone, and 1000 Islands) providing immersive residential care with detox, therapy, and aftercare; and (3) a Virtual Intensive Outpatient Program (VIOP) delivering live, encrypted telehealth-based individual and group therapy to clients nationwide. Ancillary services including Hepatitis C screening/treatment, Harm Reduction (needle exchange and Naloxone kits), and a Behavioural Addiction program are integrated across all pathways.

Differentiator

Problem solved

Functional benefit

Brands

• Virtual Intensive Outpatient Program (VIOP): Proprietary 100% virtual addiction treatment program built on CARF-accredited inpatient approach, available across Canada.
• Evening Program

Products and services

• Outpatient Opioid Treatment Rapid-access outpatient treatment for opioid use disorder offering same-day intake, medication-assisted therapy with methadone or Suboxone, and integrated pharmacy and medical services across 75+ centres in Ontario, New Brunswick, and British Columbia. Designed for individuals with opioid dependency seeking barrier-free, walk-in access to evidence-based treatment.
• Methadone Treatment Program Full opioid agonist therapy using methadone (liquid or tablet form) for opioid use disorder, providing withdrawal relief and cravings reduction with no ceiling effect, suitable for patients dependent on high doses or strong opioids such as fentanyl. For individuals with opioid dependency.
• Suboxone (Buprenorphine/Naloxone) Treatment Partial opioid agonist therapy combining buprenorphine and naloxone in sublingual tablet form, reducing cravings and withdrawal symptoms with a ceiling effect that offers a better safety profile than methadone. For individuals with opioid use disorder.
• Sublocade (Monthly Buprenorphine Injection) Once-monthly subcutaneous buprenorphine injection for moderate opioid use disorder, providing long-acting withdrawal management and cravings reduction as part of a complete treatment plan including counseling. For individuals seeking lower-burden medication-assisted treatment.
• Inpatient Addiction Treatment CARF-accredited intensive residential addiction treatment across three Ontario centres (Trafalgar, GreeneStone, and 1000 Islands), offering medically supervised detox, individual and group therapy, psychiatric assessment, family support, and aftercare for substance use and behavioural addictions. For individuals with substance use disorders requiring immersive, structured care.
• Virtual Intensive Outpatient Program (VIOP) 100% virtual, CARF-accredited addiction treatment program delivered via encrypted telehealth platform (PHIPA/PIPEDA-compliant), featuring live scheduled individual and group therapy, evening and refresher options, and available to clients across Canada. For working adults, rural residents, and individuals needing flexible, private treatment.
• Hepatitis C Screening and Treatment Same-day Hepatitis C screening, education, financial aid assistance for medications, and direct-acting antiviral treatment with >95% cure rates over 8-12 weeks, integrated within outpatient clinic services. For individuals with or at risk of Hepatitis C in the addiction treatment population.
• Harm Reduction Services Needle Exchange Program providing sterile injection and safe inhalation supplies (needles, tourniquets, cookers, sterile water, foil, pipes) and Naloxone overdose prevention kits at most CATC clinics and pharmacies. For individuals at various stages of addiction recovery who benefit from harm reduction to reduce risks associated with ongoing substance use.
• Opioid Use During Pregnancy Program Specialized treatment for opioid-dependent pregnant women using Methadone or Buprenorphine (with Health Canada-approved Subutex access), including postpartum and breastfeeding support coordinated with other care providers. For pregnant women with opioid use disorder who need safe, evidence-based treatment to protect both maternal and fetal health.
• Behavioural Addiction Treatment Treatment for behavioural addictions including sex, pornography, gambling, and internet/social media addiction, offered through the Virtual Intensive Outpatient Program alongside concurrent mental health disorder treatment for anxiety, depression, bipolar, OCD, PTSD, ADHD, and panic disorder. For individuals with behavioural addictions or co-occurring mental health conditions.

Quantifiable outcome

• 98% of clients say their lives improved after treatment
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Community Agencies (Unnamed)coreStrategic or Co-development PartnerCATC partners with community agencies to provide additional services including counseling, housing support, job banks, tax filing assistance, and primary care. These partnerships enhance the comprehensive care model by addressing social determinants of health.
• Healthcare Providers in British ColumbiacoreStrategic or Co-development PartnerCATC works hand-in-hand with healthcare providers, community agencies, and government in BC to increase access to Opioid Agonist Treatment (OAT) and address the overdose crisis. Activities include educational sessions, virtual physician access, and community engagement initiatives.
• Ontario Harm Reduction Distribution ProgramminorOthersContact for information and resources on opioid overdose prevention and response. Provides naloxone kits and harm reduction supplies to CATC patients.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Homewood Health: Canadian provider of mental health, addiction, and recovery services including residential treatment and outpatient programs; one of the closest comparables to CATC in Canada in terms of integrated addiction and behavioural health offerings.
• Edgewood Health Network (EHN): Canadian network of residential and outpatient addiction and mental health treatment facilities; competes with CATC's inpatient centres and virtual offerings for the same patient population across multiple provinces.
• Bellwood Health Services: Toronto-based residential addiction and mental health treatment provider offering inpatient programs comparable to CATC's Trafalgar, GreeneStone, and 1000 Islands facilities.
• Renascent: Canadian addiction treatment organization offering outpatient and residential programs including a focused opioids program; directly comparable in service mix and patient demographic to CATC.
• Portage: Operates residential addiction treatment centres across Canada for youth and adults; comparable to CATC's inpatient arm and frequently referenced as a peer in Canadian addiction policy discussions.
• BayMark Health Services: Largest US provider of opioid use disorder treatment with a network of methadone and buprenorphine clinics plus telehealth; most direct international comparable to CATC's OAT outpatient and pharmacy-integrated model.

Broad incumbents

• Acadia Healthcare: Large publicly-traded behavioural health operator with a substantial addiction treatment footprint including residential facilities; a broad incumbent benchmark for scale, M&A multiples, and clinical operating leverage in addiction care.
• Caron Treatment Centers: US non-profit addiction treatment provider with residential and outpatient programs serving North American patients including Canadians; comparable on inpatient care model and CARF-style accreditation standards.
• Hazelden Betty Ford Foundation: US-based addiction treatment leader with residential, outpatient, and virtual programming; relevant benchmark for CATC's CARF-accredited VIOP and integrated care positioning.

Emerging players

• Canadian Centre for Addictions: Canadian residential and outpatient addiction treatment provider; smaller scale but directly competes for private-pay residential patients in the same geographies CATC serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/catc_oatc
• Facebookfacebook.com/CanadianAddictionTreatmentCentres
• LinkedInlinkedin.com/company/canadianaddictiontreatmentcentre
• Instagraminstagram.com/catcrecovery

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles29 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Addiction Treatment Centres